Skip to main content
PBH
NYSE Life Sciences

Prestige Guides FY27 Sales to $1.28B-$1.29B as Clear Eyes Supply Constraints Weigh

Tom Rudovsky · Reported by Wiseek News
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$50.5
Mkt Cap
$2.524B
52W Low
$42.62
52W High
$71.07
52W Position info
18% above low
Off High info
29% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

PBH sits 18% above its 52-week low of $42.62.

Summary

Prestige set FY27 revenue guidance at $1.28B-$1.29B and adjusted diluted EPS at $4.48-$4.55, with the outlook reflecting expected lower Clear Eyes availability in the second half. Q2 revenue rose 22.7% to $336.3M from $274.1M, but that growth was acquisition-supported — revenue fell 1.6% excluding foreign currency and $65.1M from acquisitions. Adjusted EPS came in at $1.13 versus $1.07 a year ago, while GAAP net income dropped to $25.3M from $42.2M on acquisition-related costs. H1 adjusted free cash flow slipped to $123.0M from $133.6M. The guidance is the key new piece here: the company did not previously disclose these ranges, and the Clear Eyes supply issue is the swing factor for the second half.

At the time of this announcement, PBH was trading at $50.50 on NYSE in the Life Sciences sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $42.62 to $71.07. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

PBH - Latest Insights

PBH
Nov 05, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $50.50
Real-time Price: $49.60 info
Change: -$0.8997 (-2%) info
Market Cap: $2.351B info
PBH
Aug 06, 2026, 6:15 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $52.97
Real-time Price: $49.60 info
Change: -$3.37 (-6%) info
Market Cap: $2.351B info
PBH
Aug 06, 2026, 6:04 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $52.97
Real-time Price: $49.60 info
Change: -$3.37 (-6%) info
Market Cap: $2.351B info
PBH
Aug 06, 2026, 6:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $52.97
Real-time Price: $49.60 info
Change: -$3.37 (-6%) info
Market Cap: $2.351B info
PBH
Jul 15, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $48.36
Real-time Price: $49.60 info
Change: +$1.24 (+3%) info
Market Cap: $2.351B info